Test Price
2,800 AEDโ Home Collection Available
ATXN7 Gene (Spinocerebellar Ataxia Type 7) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Post-Test Genetic Counselling by a DHA-licensed Consultant Medical Geneticist for comprehensive result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The ATXN7 genetic test uses Next-Generation Sequencing (NGS) to detect pathogenic CAG repeat expansions in the ATXN7 gene, providing definitive molecular evidence for patients with progressive ataxia, visual loss, and a family history of neurological disorders.
| Feature | Our Test (NGS Panel) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Single-nucleotide resolution with complete CAG repeat sizing | Limited to targeted region; may miss mosaicism |
| Method | NGS + bioinformatic CAG repeat expansion analysis | Sanger sequencing with fragment analysis |
| Speed | 3โ4 weeks with clinical report | 4โ6 weeks, often requires repeat testing |
Physician Insight & Safety Protocols
โAs a Consultant Medical Geneticist, I emphasise that a positive ATXN7 result confirms the genetic aetiology of Spinocerebellar Ataxia Type 7, but must be correlated with clinical findings and family history. A negative result does not exclude other hereditary ataxias. Genetic counselling is mandatory before and after sampling. Do not interpret this test in isolation or alter any prescribed medications without consulting your treating physician.โ
โ Lina Osama Zaki Quteineh, DHA Registration ID: 9294403
Medication & Safety Advisory
โ Critical Medication Notice
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation of antiepileptics, antidepressants, or other neurologically active drugs can precipitate severe withdrawal symptoms or disease exacerbation. Continue all therapies unless your physician advises otherwise.
Exclusion Criteria & Emergency Red Flags
- Inappropriate sample type (e.g., saliva, buccal swab without prior approval).
- Minors without court-ordered consent or verified parental/guardian authorisation.
- Individuals unable to provide informed consent or without a pre-test genetic counselling session.
- ER Red Flags: Sudden loss of vision, severe dysphagia, acute respiratory distress, or loss of consciousness within weeks of onset โ seek immediate emergency care; these may indicate rapid disease progression unrelated to test status.
Patient FAQ & Clinical Guidance
1. What is the ATXN7 Genetic Test and how is it performed?
The ATXN7 genetic test is a Next-Generation Sequencing analysis that detects CAG repeat expansions in the ATXN7 gene to diagnose Spinocerebellar Ataxia Type 7. A small peripheral blood sample is collected via VIP Mobile Phlebotomy under temperature-controlled cold-chain logistics. NGS technology precisely counts the number of CAG repeats, and results are interpreted alongside a genetic counsellor and your neurologist to confirm autosomal dominant inheritance and guide prognosis.
2. How do I pay or claim insurance for this test?
We offer direct insurance billing verification via WhatsApp at +971 54 548 8731 before sample collection to confirm coverage. If paying out-of-pocket, the cost is 2800 AED, payable online via secure link or upon phlebotomist arrival. Most UAE insurers cover genetic testing for neurological disorders when medically indicated; we assist with pre-authorisation forms and provide an itemised receipt for reimbursement.
3. Is the test painful and how long do results take?
The blood draw is a routine, minimally uncomfortable procedure completed within minutes. Turnaround time is 3โ4 weeks from sample receipt. You will receive a detailed clinical report with genetic findings, interpretation, and recommendations for follow-up genetic counselling. Results are provided in English and are reviewed by a Consultant Medical Geneticist before release.
UAE Regulatory & Data Privacy Adherence
Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): All genetic data and personal health information are encrypted, processed within secure UAE-based servers, and never shared with third parties without explicit patient consent.
Federal Law No. 2 of 2019: Use of information and communication technology in health fields governs the digital transmission and storage of laboratory results and telemedicine consultations.
Federal Decree-Law No. 4 of 2016 on Medical Liability: Ensures that all clinical procedures, including genetic sampling and result disclosure, meet the highest standards of patient safety and informed consent.
ISO 9001:2015 Accreditation: Cert: INT/EGQ/2509DA/3139 โ our laboratory management system is audited annually for quality and continual improvement.
Clinical & Logistical Metadata
| Test Name | ATXN7 Gene (Spinocerebellar Ataxia Type 7) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (3โ5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) with bioinformatic CAG repeat expansion analysis |
| ICD-10-CM Code | G11.8 (Other hereditary ataxias) |
| LOINC Code | 92747-7 (ATXN7 gene CAG repeat expansion analysis) |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians